Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study

PaperCitations, authors & open-access status

T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 104 citations, 2024 year and closed oa status.

104
Citations
2024
Year
closed
OA Status

Related on ScholarIQ

Kedar Kirtane
Author
Cancer Discovery
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
CAR-T cell therapy research
Topic
Immunotherapy and Immune Responses
Topic
470M+ articles · free account